Hearing on the Review of the Proposed Generic Drug and Biosimilars User Fees and Further Examination of Drug Shortages [electronic resource]

Similar Items

• Hearing on "Examining FDA's Generic Drug and Biosimilar User Fee Programs."
  Published: (2017)
• Hearing Entitled "Examining FDA's Generic Drug and Biosimilar User Fee Programs"
  Published: (2017)
• Generic Drug User Fees : Application Review Times Declined, but FDA Should Develop a Plan for Administering Its Unobligated User Fees.
  Published: (2017)
• The Generic Drug User Fee Amendments (GDUFA) : Background and Reauthorization.
  Published: (2021)
• Review of the proposed generic drug and biosimilars user fees and further examination of drug shortages : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, second session, February 9, 2012.
  Published: (2013)